Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti - An unusual phenomenon and a fascinating pathologic mechanism

被引:30
作者
Bodak, N [1 ]
Hadj-Rabia, S [1 ]
Hamel-Teillac, D [1 ]
de Prost, Y [1 ]
Bodemer, C [1 ]
机构
[1] Hop Necker Enfants Malad, Serv Dermatol, F-75015 Paris, France
关键词
D O I
10.1001/archderm.139.2.201
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Incontinentia pigmenti (IP) is an X-linked genodermatosis that is manifested by neonatal inflammatory vesicles localized along the lines of Blaschko. These lesions usually clear spontaneously within a few months, leaving hyperpigmentation. Ophthalmologic and neurologic symptoms can be associated with IP. Late recurrences of the first-stage inflammatory lesions after the initial rash are uncommon and have been reported infrequently. The mechanism involved in this phenomenon is unclear. However, the recent identification of NEMO/IKKgamma as the gene responsible for IP sheds new light on its pathophysiologic origins. Observations: We report 5 cases of children who experienced episodes of late reactivation of IP. In all cases, the recurrences occurred on the previously hyperpigmented streaks several months or years after resolution of the initial eruptions. In most cases, the recurrences were preceded by an infectious episode. Conclusions: These IP recurrences suggest that mutated cells can persist a long time in the epidermis. We theorize that infections trigger the reactivations. The NEMO/IKKgamma gene encodes a protein essential in nuclear factor kappaB activation, which is required for resistance to tumor necrosis factor alpha-induced apoptosis. We discuss the role of A proinflammatory cytokine such as tumor necrosis factor alpha as a triggering factor for the reactivation.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 17 条
[1]   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine [J].
Asea, A ;
Kraeft, SK ;
Kurt-Jones, EA ;
Stevenson, MA ;
Chen, LB ;
Finberg, RW ;
Koo, GC ;
Calderwood, SK .
NATURE MEDICINE, 2000, 6 (04) :435-442
[2]  
BARNES CM, 1978, CUTIS, V22, P621
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[5]   PROGRESSIVE, PERSISTENT, HYPERKERATOTIC LESIONS IN INCONTINENTIA PIGMENTI [J].
BESSEMS, PJMJ ;
JAGTMAN, BA ;
VANDESTAAK, WJBM ;
HULSMANS, RFHJ ;
CROUGHS, KJM .
ARCHIVES OF DERMATOLOGY, 1988, 124 (01) :29-30
[6]  
HAPPLE R, 1985, HUM GENET, V70, P200
[7]   INCONTINENTIA PIGMENTI (BLOCH-SULZBERGER SYNDROME) [J].
LANDY, SJ ;
DONNAI, D .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (01) :53-59
[8]   Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti [J].
Makris, C ;
Godfrey, VL ;
Krähn-Senftleben, G ;
Takahashi, T ;
Roberts, JL ;
Schwarz, T ;
Feng, LL ;
Johnson, RS ;
Karin, M .
MOLECULAR CELL, 2000, 5 (06) :969-979
[9]  
Nagase T, 1997, Australas J Dermatol, V38, P155, DOI 10.1111/j.1440-0960.1997.tb01135.x
[10]   Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2 [J].
Parrish, JE ;
Scheuerle, AE ;
Lewis, RA ;
Levy, ML ;
Nelson, DL .
HUMAN MOLECULAR GENETICS, 1996, 5 (11) :1777-1783